RESEARCH ARTICLE


Risk of Exposure to Marketed Milk with Antimicrobial Drug Residues in Ghana



K.G. Aning*, 1, E.S. Donkor1, 4, A. Omore2, G.K. Nurah3, E.L.K. Osafo3, S. Staal2
1 Animal Research Institute, Council for Scientific and Industrial Research, Achimota, Ghana
2 International Livestock Research Institute, Nairobi, Kenya
3 Faculty of Agriculture, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
4 Department of Microbiology, University of Ghana Medical School, College of Health Sciences, Accra, Ghana


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 178
Abstract HTML Views: 680
PDF Downloads: 140
Total Views/Downloads: 998
Unique Statistics:

Full-Text HTML Views: 140
Abstract HTML Views: 468
PDF Downloads: 101
Total Views/Downloads: 709



© 2007 Aning et al.;

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Microbiology, University of Ghana Medical School, College of Health Sciences, Accra, Ghana; E-mail: ericsdon@hotmail.com


Abstract

The study was carried out to determine the extent to which antimicrobial drugs may be translocated into milk and the associated risk of exposure by consumers. A total of 394 milk samples were collected in the study sites in dry and wet seasons, and from different categories of milk market agents, including producers (farmers), processors, wholesalers (assemblers) and retailers. The milk samples were screened for antimicrobial drug residues using the Charm Aim-96 antimicrobial inhibition assay screening kit. Overall, 35.5% (140/394) of the milk samples collected were contaminated with one or more of the antimicrobial drugs screened. This translates into an average risk of exposure every third time a consumer drinks locally produced milk. There was no significant difference in contamination levels between season and area of sampling. Among market agents, contamination levels ranged from 16.6% (9/54) for wholesalers or milk assemblers to 54.2% (13/24) for milk processors. There were no significant differences in prevalence proportions of drug residues in milk from different types of traders between and within locations.